NPS Pharmaceuticals (NASDAQ:NPSP) CFO Luke M. Beshar sold 30,635 shares of the stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $26.75, for a total value of $819,486.25. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) belongs to Healthcare sector. Its net profit margin is 1.10% and weekly performance is 1.75%. On last trading day company shares ended up $27.40. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) distance from 50-day simple moving average (SMA50) is 0.73%. Shares of AK Steel Holding (NYSE:AKS) have received a consensus rating of “Hold” from the eleven analysts that are covering the stock, Stock Ratings News reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and six have assigned a buy recommendation to the company. AK Steel Holding Corporation (NYSE:AKS) shares advanced 4.13% in last trading session and ended the day at $7.57. AKS Gross Margin is 7.00% and its return on assets is -2.70%. AK Steel Holding Corporation (NYSE:AKS) quarterly performance is -19.30%. Newmont Mining Corporation (NYSE:NEM)’s profit fell 46% in the third quarter as the company reported lower gold and copper production and continued to grapple with lower prices. The Greenwood Village, Colo., gold-mining company, the world’s second largest by production, has been one of the worst performers in the S&P 500. Through Thursday’s close, the company’s stock was down nearly 12% for the year. On 31 October, Newmont Mining Corporation (NYSE:NEM) shares decreased -7.72% and was closed at $18.76. NEM EPS growth in last 5 year was -37.00%. Newmont Mining Corporation (NYSE:NEM) year to date (YTD) performance is -17.86%. Endologix Inc. (NASDAQ:ELGX) announced financial results for the three and nine months ended September 30, 2014. Global revenue in the third quarter of 2014 was $37.2 million, a 12% increase from $33.3 million in the third quarter of 2013. For the nine months ended September 30, 2014, global revenue increased 12% to $108.7 million, compared to $97.0 million for the nine months ended September 30, 2013. Endologix Inc. (NASDAQ:ELGX) ended the last trading day at $11.40. Company weekly volatility is calculated as 5.93% and price to cash ratio as 6.89. Endologix Inc. (NASDAQ:ELGX) showed a weekly performance of -0.09%. On Oct. 15, Malvern Bancorp, Inc. (NASDAQ:MLVF), has announced changes in leadership of the boards of directors of the Company and the Bank. Vice chairman George E. Steinmetz has assumed the chairmanship, and board member Therese H. Woodman has been named vice chair of the Company's and the Bank's board of directors. F. Claire Hughes, who previously served as chairman of the board, will continue to serve as a director. Malvern Bancorp, Inc. (NASDAQ:MLVF) shares decreased -0.27% in last trading session and ended the day at $11.23. MLVF return on assets is -3.20%. Malvern Bancorp, Inc. (NASDAQ:MLVF) quarterly performance is 0.81%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
